Cargando…
Recalcitrant nodular scabies showing excellent response to tofacitinib: five case reports
Scabies is a contagious skin condition caused by Sarcoptes scabiei, and it is always associated with an intense, unbearable, nocturnal deteriorating itch. Its presentations include classic burrows, erythema, pruritic papules, pustules, vesicles, and inflammatory nodules, with diffuse or localized di...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10467300/ https://www.ncbi.nlm.nih.gov/pubmed/37655266 http://dx.doi.org/10.1177/20406223231195632 |
_version_ | 1785099086635991040 |
---|---|
author | Zhao, Yu-Kun Lu, Jing-Fa Liu, Juan-Hua Wu, Hui-Hui Song, Lu-Li Wan, Chun-Lei Luo, Di-Qing |
author_facet | Zhao, Yu-Kun Lu, Jing-Fa Liu, Juan-Hua Wu, Hui-Hui Song, Lu-Li Wan, Chun-Lei Luo, Di-Qing |
author_sort | Zhao, Yu-Kun |
collection | PubMed |
description | Scabies is a contagious skin condition caused by Sarcoptes scabiei, and it is always associated with an intense, unbearable, nocturnal deteriorating itch. Its presentations include classic burrows, erythema, pruritic papules, pustules, vesicles, and inflammatory nodules, with diffuse or localized distribution on the finger webs, wrist flexors, elbows, axillae, buttocks, genitalia, and breasts. Nodular scabies is an uncommon clinical variant of scabies. Its management is still challenging for some patients up to date, although topical, intralesional or systemic corticosteroids, topical calcineurin inhibitors, and crotamiton as well as cryotherapy alone or in different combinations are used. We here report five male patients of nodular scabies, aged between 14 and 25 years, who had classical scabies that had been cured by sulfur ointment for at least 4 weeks except for their itching nodules, and their residual pruritic nodules also failed in previous treatments including antihistamines, topical applying and intralesional injection of steroids as well as topical tacrolimus in different combinations before being recruited to this study. The patients were administered tofacitinib 5 mg, twice a day, which led to excellent and rapid improvement for both lesions and symptoms after 1–4 weeks of treatment, respectively, without any associations. During 6 months of follow-up, only one had re-infection of scabies associated with nodules that were cured by sulfur ointment and tofacitinib again. No adverse reaction was observed. The present results suggested that tofacitinib might be a potential agent for nodular scabies with excellent response. |
format | Online Article Text |
id | pubmed-10467300 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-104673002023-08-31 Recalcitrant nodular scabies showing excellent response to tofacitinib: five case reports Zhao, Yu-Kun Lu, Jing-Fa Liu, Juan-Hua Wu, Hui-Hui Song, Lu-Li Wan, Chun-Lei Luo, Di-Qing Ther Adv Chronic Dis Case Series Scabies is a contagious skin condition caused by Sarcoptes scabiei, and it is always associated with an intense, unbearable, nocturnal deteriorating itch. Its presentations include classic burrows, erythema, pruritic papules, pustules, vesicles, and inflammatory nodules, with diffuse or localized distribution on the finger webs, wrist flexors, elbows, axillae, buttocks, genitalia, and breasts. Nodular scabies is an uncommon clinical variant of scabies. Its management is still challenging for some patients up to date, although topical, intralesional or systemic corticosteroids, topical calcineurin inhibitors, and crotamiton as well as cryotherapy alone or in different combinations are used. We here report five male patients of nodular scabies, aged between 14 and 25 years, who had classical scabies that had been cured by sulfur ointment for at least 4 weeks except for their itching nodules, and their residual pruritic nodules also failed in previous treatments including antihistamines, topical applying and intralesional injection of steroids as well as topical tacrolimus in different combinations before being recruited to this study. The patients were administered tofacitinib 5 mg, twice a day, which led to excellent and rapid improvement for both lesions and symptoms after 1–4 weeks of treatment, respectively, without any associations. During 6 months of follow-up, only one had re-infection of scabies associated with nodules that were cured by sulfur ointment and tofacitinib again. No adverse reaction was observed. The present results suggested that tofacitinib might be a potential agent for nodular scabies with excellent response. SAGE Publications 2023-08-29 /pmc/articles/PMC10467300/ /pubmed/37655266 http://dx.doi.org/10.1177/20406223231195632 Text en © The Author(s), 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Case Series Zhao, Yu-Kun Lu, Jing-Fa Liu, Juan-Hua Wu, Hui-Hui Song, Lu-Li Wan, Chun-Lei Luo, Di-Qing Recalcitrant nodular scabies showing excellent response to tofacitinib: five case reports |
title | Recalcitrant nodular scabies showing excellent response to tofacitinib: five case reports |
title_full | Recalcitrant nodular scabies showing excellent response to tofacitinib: five case reports |
title_fullStr | Recalcitrant nodular scabies showing excellent response to tofacitinib: five case reports |
title_full_unstemmed | Recalcitrant nodular scabies showing excellent response to tofacitinib: five case reports |
title_short | Recalcitrant nodular scabies showing excellent response to tofacitinib: five case reports |
title_sort | recalcitrant nodular scabies showing excellent response to tofacitinib: five case reports |
topic | Case Series |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10467300/ https://www.ncbi.nlm.nih.gov/pubmed/37655266 http://dx.doi.org/10.1177/20406223231195632 |
work_keys_str_mv | AT zhaoyukun recalcitrantnodularscabiesshowingexcellentresponsetotofacitinibfivecasereports AT lujingfa recalcitrantnodularscabiesshowingexcellentresponsetotofacitinibfivecasereports AT liujuanhua recalcitrantnodularscabiesshowingexcellentresponsetotofacitinibfivecasereports AT wuhuihui recalcitrantnodularscabiesshowingexcellentresponsetotofacitinibfivecasereports AT songluli recalcitrantnodularscabiesshowingexcellentresponsetotofacitinibfivecasereports AT wanchunlei recalcitrantnodularscabiesshowingexcellentresponsetotofacitinibfivecasereports AT luodiqing recalcitrantnodularscabiesshowingexcellentresponsetotofacitinibfivecasereports |